SCHEMBL7815314

SCHEMBL7815314

Cc1ccc(-c2nc3c(s2)C(=O)c2ccc(F)cc2C3=O)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.40
TDO2 P48775 2/20 0.40
USP8 P40818 1/20 0.38
USP7 Q93009 1/20 0.38
USP47 Q96K76 1/20 0.38
ADORA2A P29274 6/20 0.37
ALDH1A1 P00352 4/20 0.36
MAPT P10636 4/20 0.36
PKM P14618 2/20 0.36
HPGD P15428 2/20 0.36
ATM Q13315 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
GLA P06280 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HCRTR1 O43613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813067 1.00 IDO1 (0.40) IDO1TDO2USP8USP7USP47
SCHEMBL7811891 0.85 IDO1 (0.55) IDO1TDO2ADORA2AALDH1A1MAPT
SCHEMBL7813017 0.80 IDO1 (0.43) IDO1TDO2USP8USP7USP47
SCHEMBL7813184 0.80 IDO1 (0.43) IDO1TDO2USP8USP7USP47
SCHEMBL7812596 0.79 IDO1 (0.51) IDO1TDO2USP8USP7USP47
SCHEMBL7812893 0.79 IDO1 (0.51) IDO1TDO2USP8USP7USP47
SCHEMBL7815327 0.78 IDO1 (0.56) IDO1TDO2USP8USP7USP47
SCHEMBL7812894 0.78 IDO1 (0.56) IDO1TDO2USP8USP7USP47
SCHEMBL7805861 0.76 IDO1 (0.60) IDO1TDO2USP8USP7USP47
SCHEMBL7805662 0.76 IDO1 (0.60) IDO1TDO2USP8USP7USP47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed